Last reviewed · How we verify
NCT06238414: SAMIT
Attempted Suicide Intervention Treatment and Prevention (SAMIT Program)
NA trial testing Early psychotherapeutic intervention in Suicide, Attempted in 120 participants. Currently enrolling.
30 June 2025
Quick facts
| Lead sponsor | Hospital Universitari Vall d'Hebron Research Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 December 2023 |
| Primary completion | 30 June 2025 |
| Estimated completion | 27 April 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Early psychotherapeutic intervention
Conditions studied
- Suicide, Attempted — all drugs for Suicide, Attempted →
- Suicide Prevention — all drugs for Suicide Prevention →
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Who can join
16 and older, any sex, with Suicide, Attempted or Suicide Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Suicide has become a first-order public health concern after the negative impact of coronavirus disease 2019 (COVID-19) on the mental health of the general population. Few studies have analyzed the effects of early psychotherapeutic interventions on subjects who have attempted suicide, and even fewer focus on those hospitalized in nonpsychiatric units after a medically serious suicide attempt (MSSA). The most important risk factor for attempting suicide is having made a previous suicide attempt. Subjects are also at higher risk the first year after the attempt. The main aim of this study is to evaluate the effectiveness of individual psychological treatment with patients hospitalized after a MSSA. The secondary objectives are: 1) acknowledge the evolution of the incidence of MSSA hospitalized during the pandemic; 2) analyze the impact of the psychological intervention using biological, psychosocial, and clinical variables. An experimental, controlled, and randomized trial will be conducted with patients older than 16 admitted to two general hospitals. The case group will receive an 8- session of individual psychotherapy while the control group received treatment as usual. Longitudinal assessment will be conducted at baseline, post-treatment, and 3, 6, and 12 months after. The main outcome variable will be re-attempting suicide during the follow-up.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Suicide Attempt Multicomponent Intervention Treatment (SAMIT Program): study protocol for a multicentric randomised controlled trial.
Beneria A, Motger-Albertí A, Quesada-Franco M, Arteaga-Henríquez G, et al · · 2024 · cited 2× · PMID 39379877 · DOI 10.1186/s12888-024-06113-3
Verify or expand the search:
- PubMed search for NCT06238414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide, Attempted
Currently open trials in the same condition.
- NCT07219355 — Virtual Reality Lethal Means Safety Training · NA · recruiting
- NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
- NCT06151158 — Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings · NA · recruiting
- NCT06474221 — Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters · NA · recruiting
- NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting
Other Hospital Universitari Vall d'Hebron Research Institute trials
Trials by the same sponsor.
- NCT07519343 — Migraine and Endometriosis: The FEMININE Study · not yet recruiting
- NCT07509541 — Hemodynamic and Respiratory Instability During Percutaneous Pulmonary Thrombectomy · not yet recruiting
- NCT07456280 — Evaluation of the Non-invasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With · NA · not yet recruiting
- NCT07281911 — Early Biological and Mechanical Profiling in Sepsis-Associated ARDS · not yet recruiting
- NCT07430501 — Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatme · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06238414 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari Vall d'Hebron Research Institute
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing